Entrada Therapeutics, Inc.

NASDAQ:TRDA

10.82 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 101.21178.049185.25368.43667.60251.882376.789227.64845.15753.31190.86784.64291.064122.172136.947039.0450
Short Term Investments 318.787371.295284.493258.978284.367301.696297.046183.983143.555162.261153.387179.262000000
Cash and Short Term Investments 419.998449.344469.746327.414351.969353.578376.789227.64845.157215.572244.254263.902291.064122.172136.94739.04539.04516.844
Net Receivables 3.682.603077.51405.0253.7446.2970000000000
Inventory 00000-5.0250183.9830000000000
Other Current Assets 16.36113.38830.5069.24427.72624.449.66216.20721.16324.62216.09817.627.6362.7060.68900.9040
Total Current Assets 440.039465.335489.536414.172369.771383.043390.195434.135209.875234.733253.903272.712298.7123.525137.63639.04539.94916.844
Non-Current Assets:
Property, Plant & Equipment, Net 82.04884.55987.7389.9692.68195.05999.323.64133.02134.82637.18938.6066.2615.9015.08703.0370
Goodwill 000000000000000000
Intangible Assets 000000000000000000
Goodwill and Intangible Assets 000000000000000000
Long Term Investments 003.953.953.953.953.953.953.953.953.950000000
Tax Assets 000000000000000000
Other Non-Current Assets 4.2344.6960.7472.7622.792.9810.53813.8435.210.9540.8755.3840.8722.9690.791-39.0450.541-16.844
Total Non-Current Assets 86.28289.25592.42796.67299.421101.99103.78841.43442.18139.7342.01443.997.1338.875.878-39.0453.578-16.844
Total Assets 526.321554.59581.963510.844469.192485.033493.983475.569252.056274.463295.917316.702305.833132.395143.514043.5270
Liabilities & Equity:
Current Liabilities:
Account Payables 4.2591.2921.6352.5273.2770.7522.4226.4745.991.3414.6222.9310.7062.2781.88101.6020
Short Term Debt 7.55915.47617.1348.30115.81813.28414.81814.2068.40616.51816.22815.942000000
Tax Payables 0.6672.2514.1115.8554.02407.3593.5510000000000
Deferred Revenue 13.65445.91960.497148.463132.261148.44101.645122.3410000000000
Other Current Liabilities 13.3435.6652.4328.7923.4162.957-0.3041.0227.5763.692-2.773-3.4476.0134.882.65501.7570
Total Current Liabilities 39.48270.60385.809173.938158.796165.433125.94147.59421.97221.55118.07715.4266.7197.1584.53603.3590
Non-Current Liabilities:
Long Term Debt 51.64853.57655.87658.13160.32162.43165.6249.12217.5319.69221.80123.885000000
Deferred Revenue Non-Current 6.5137.96410.3539.4087.71510.50695.51189.2410000000000
Deferred Tax Liabilities Non-Current 00-10.353-9.408-60.321-10.506-95.511-89.2410000000000
Other Non-Current Liabilities 0000000000000.396197.828197.992-40.16881.658-16.298
Total Non-Current Liabilities 58.16161.5466.22967.53968.03672.937161.13598.36317.5319.69221.80123.8850.396197.828197.992-40.16881.658-16.298
Total Liabilities 97.643132.143152.038241.477226.832238.37287.075245.95739.50241.24339.87839.3117.115204.986202.528-40.16885.017-16.298
Equity:
Preferred Stock 0000000000000197.489081.658031.816
Common Stock 0.0040.0040.0040.0030.0030.0030.0030.0030.0030.0030.0030.0030.00300000
Retained Earnings -129.344-130.475-116.443-171.474-194.97-185.426-220.887-194.959-188.285-163.656-138.519-115.34-93.669-75.222-60.7920-42.5110
Accumulated Other Comprehensive Income/Loss -0.0430.972-0.329-0.2460.195-0.496-1.005-0.642-2.057-2.747-2.265-1.535000-41.490-15.518
Other Total Stockholders Equity 558.061551.946546.693441.084437.132432.582428.797425.21402.893399.62396.82394.263392.3842.6311.77801.021-0
Total Shareholders Equity 428.678422.447429.925269.367242.36246.663206.908229.612212.554233.22256.039277.391298.718-72.591-59.01440.168-41.4916.298
Total Equity 428.678422.447429.925269.367242.36246.663206.908229.612212.554233.22256.039277.39100040.168016.298
Total Liabilities & Shareholders Equity 526.321554.59581.963510.844469.192485.033493.983475.569252.056274.463295.917316.702305.833132.395143.514043.5270